journal article·2023-01-12Open access

Icariin: A Promising Natural Product in Biomedicine and Tissue Engineering

Zahra Seyedi, Mohammad Sadegh Amiri, Vahideh Mohammadzadeh, Alireza Hashemzadeh, Aliakbar Haddad-Mashadrizeh, Mohammad Mashreghi, Mohsen Qayoomian, Mohammad Reza Hashemzadeh, Jesus Simal-Gandara, Mohammad Ehsan Taghavizadeh Yazdi

Abstract

Among scaffolds used in tissue engineering, natural biomaterials such as plant-based materials show a crucial role in cellular function due to their biocompatibility and chemical indicators. Because of environmentally friendly behavior and safety, green methods are so important in designing scaffolds. A key bioactive flavonoid of the Epimedium plant, Icariin (ICRN), has a broad range of applications in improving scaffolds as a constant and non-immunogenic material, and in stimulating the cell growth, differentiation of chondrocytes as well as differentiation of embryonic stem cells towards cardiomyocytes. Moreover, fusion of ICRN into the hydrogel scaffolds or chemical crosslinking can enhance the secretion of the collagen matrix and proteoglycan in bone and cartilage tissue engineering. To scrutinize, in various types of cancer cells, ICRN plays a decisive role through increasing cytochrome c secretion, Bax/Bcl2 ratio, poly (ADP-ribose) polymerase as well as caspase stimulations. Surprisingly, ICRN can induce apoptosis, reduce viability and inhibit proliferation of cancer cells, and repress tumorigenesis as well as metastasis. Moreover, cancer cells no longer grow by halting the cell cycle at two checkpoints, G0/G1 and G2/M, through the inhibition of NF-κB by ICRN. Besides, improving nephrotoxicity occurring due to cisplatin and inhibiting multidrug resistance are the other applications of this biomaterial.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Medicinal Plant Pharmacodynamics Research · Natural product bioactivities and synthesis · Phytochemical compounds biological activities

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Stem Cells and Regenerative Medicine, Royesh Stem Cell Biotechnology Institute, Mashhad 9188758156, Iran

Department of Cancer and Oncology, Royesh Stem Cell Biotechnology Institute, Mashhad 9188758156, Iran

Department of Biology, Payame Noor University, Tehran 19395-4697, Iran

Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad 91778, Iran

Industrial Biotechnology Research Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad 9177948974, Iran

Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad 91778, Iran

Nutrition and Bromatology Group, Department of Analytical and Food Chemistry, Faculty of Food Science and Technology, University of Vigo, Ourense Campus, E32004 Ourense, Spain

References (100+)

Show source-provided references
1. Plant-derived synthesis and characterization of gold nanoparticles: Investigation of its antioxidant and anticancer activity against human testicular embryonic carcinoma stem cells10.1016/j.procbio.2021.09.010 ↗
2. Yazdi, M.E., Amiri, M.S., and Darroudi, M. (2019). Biopolymers in the Synthesis of Different Nanostructures. Reference Module in Materials Science and Materials Engineering, Elsevier.10.1016/B978-0-12-803581-8.10560-0 ↗
3. Darroudi, M., Yazdi, M.E.T., and Amiri, M.S. (2020). Plant-Mediated Biosynthesis of Nanoparticles. 21st Century Nanoscience—A Handbook, CRC Press.10.1201/9780429351525-1 ↗
4. Bio-indicators in cadmium toxicity: Role of HSP27 and HSP7010.1007/s11356-021-13687-y ↗
5. The Expression of Antioxidant Genes and Cytotoxicity of Biosynthesized Cerium Oxide Nanoparticles Against Hepatic Carcinoma Cell Line10.34172/ajmb.2019.04 ↗
6. Medicinal plants and phytotherapy in Iran: Glorious his-tory, current status and future prospects10.14719/pst.2021.8.1.926 ↗
7. Alabyadh, T., Albadri, R., Es-Haghi, A., Yazdi, M.E.T., Ajalli, N., Rahdar, A., and Thakur, V.K. (2022). ZnO/CeO2 Nanocomposites: Metal-Organic Framework-Mediated Synthesis, Characterization, and Estimation of Cellular Toxicity toward Liver Cancer Cells. J. Funct. Biomater., 13.10.3390/jfb13030139 ↗
8. Nadaf, M., Abad, M.H.K., Gholami, A., Yazdi, M.E.T., Iriti, M., and Mottaghipisheh, J. (2022). Phenolic content and antioxidant activity of different Iranian populations of Anabasis aphylla L.. Nat. Prod. Res.10.1080/14786419.2022.2150621 ↗
9. Resveratrol-Mediated Gold-Nanoceria Synthesis as Green Nanomedicine for Phytotherapy of Hepatocellular Carcinoma10.31083/j.fbl2708227 ↗
10. Farhangi, M.J., Es-Haghi, A., Yazdi, M.E.T., Rahdar, A., and Baino, F. (2021). MOF-Mediated Synthesis of CuO/CeO2 Composite Nanoparticles: Characterization and Estimation of the Cellular Toxicity against Breast Cancer Cell Line (MCF-7). J. Funct. Biomater., 12.10.3390/jfb12040053 ↗
11. Crossing kingdoms: Using decellularized plants as perfusable tissue engineering scaffolds10.1016/j.biomaterials.2017.02.011 ↗
12. Es-Haghi, A., Yazdi, M.T., Sharifalhoseini, M., Baghani, M., Yousefi, E., Rahdar, A., and Baino, F. (2021). Application of Response Surface Methodology for Optimizing the Therapeutic Activity of ZnO Nanoparticles Biosynthesized from Aspergillus niger. Biomimetics, 6.10.3390/biomimetics6020034 ↗
13. Stem cell therapy in the heart: Biomaterials as a key route10.1016/j.tice.2021.101504 ↗
14. Biological synthesis and characterization of gold nanoparticles using Verbascum speciosum Schrad. and cytotoxicity properties toward HepG2 cancer cell line
15. Biocomponents and Antioxidant Activity of Ribes khorasanicum10.15171/ijbsm.2018.18 ↗
16. Assessment of phytochemical components and antioxidant activity of Rheum turkestanicum Janisch
17. Plant-based synthesis of silver nanoparticles in Handelia trichophylla and their biological activi-ties10.1007/s12034-019-1855-8 ↗
18. Anticancer, antimicrobial, and dye degradation activity of biosynthesised silver nanoparticle using Artemisia kopetdaghensis10.1049/mnl.2020.0387 ↗
19. From plants to antimicrobials: Natural products against bacterial membranes10.1002/ptr.7275 ↗
20. Elicitation Improves Phenolic Acid Content and Antioxidant Enzymes Activity in Salvia leriifolia Cell Cultures10.1007/s40995-021-01070-y ↗
21. Greener synthesis of cerium oxide nanoemulsion using pollen grains of Brassica napus and evaluation of its antitumour and cytotoxicity properties10.1080/10667857.2020.1863558 ↗
22. Antimycobacterial, Anticancer, Antioxidant and Photocatalytic Activity of Bio-synthesized Silver Nanoparticles Using Berberis Integerrima
23. Applications of plant-based nanoparticles in nanomedicine: A review10.1016/j.scp.2022.100606 ↗
24. Ultrasound-based synthesis of ZnO·Ag2O3 nanocomposite: Characterization and evaluation of its antimicrobial and anticancer properties10.1007/s11164-020-04355-w ↗
25. Silver-zinc oxide nanocomposite: From synthesis to antimicrobial and anticancer properties10.1016/j.ceramint.2021.04.160 ↗
26. Biomaterializing the promise of cardiac tissue engineering10.1016/j.biotechadv.2019.02.009 ↗
27. Current advances in microsphere based cell culture and tissue engineering10.1016/j.biotechadv.2019.107459 ↗
28. Use of an in vitro model in tissue engineering to study wound repair and differentiation of blastema tissue from rabbit pinna10.1007/s11626-015-9868-0 ↗
29. Icariin promotes mouse Leydig cell testosterone synthesis via the Esr1/Src/Akt/Creb/Sf-1 pathway10.1016/j.taap.2022.115969 ↗
30. Icariin improves brain function decline in aging rats by enhancing neuronal autophagy through the AMPK/mTOR/ULK1 pathway10.1080/13880209.2021.1878238 ↗
31. Pharmacological effects and pharmacokinetic properties of icariin, the major bioactive component in Herba Epimedii10.1016/j.lfs.2015.01.006 ↗
32. Liu, Y., Yang, H., Xiong, J., Zhao, J., Guo, M., Chen, J., Zhao, X., Chen, C., He, Z., and Zhou, Y. (2023). Icariin as an emerging candidate drug for anticancer treatment: Current status and perspective. Biomed. Pharmacother., 157.10.1016/j.biopha.2022.113991 ↗
33. The controlled release of a novel thiolated icariin for enhanced osteoporotic bone regeneration10.1016/j.matdes.2021.109468 ↗
34. Icariin attenuates bleomycin-induced pulmonary fibrosis by targeting Hippo/YAP pathway10.1016/j.biopha.2021.112152 ↗
35. Icariin attenuates renal fibrosis in chronic kidney disease by inhibiting interleukin-1β/transforming growth factor-β-mediated activation of renal fibroblasts10.1002/ptr.7256 ↗
36. Icariin and Its Metabolites as Potential Protective Phytochemicals Against Alzheimer’s Disease10.3389/fphar.2019.00271 ↗
37. Pharmacopoeia, C. (2020). Chinese Pharmacopoeia Commission Chinese Pharmacopoeia, Chinese Medical Science and Technology Press.
38. (2023, January 01). The Plant List, 2013. Version 1.1. Published on the Internet. Available online: http://www.theplantlist.org/.
39. Taxonomic, genetic, chemical and estrogenic characteristics of Epimedium species10.1016/j.phytochem.2007.03.001 ↗
40. A New Species of Epimedium (Berberidaceae) from Hubei, China10.3417/2007161 ↗
41. Analysis of active ingredients of traditional Chinese herbal drug. Assay of icariin in Epimedium
42. The genus Epimedium: An ethnopharmacological and phytochemical review10.1016/j.jep.2011.01.001 ↗
43. A systematic review of the efficacy and pharmacological profile of Herba Epimedii in osteoporosis therapy
44. Icariin ameliorates metabolic syndrome-induced benign prostatic hyperplasia in rats10.1007/s11356-021-17245-4 ↗
45. Combined protective effects of icariin and selenomethionine on novel chronic tubulointerstitial nephropathy models in vivo and in vitro10.1017/S0007114521000787 ↗
46. Icariin improves pig sperm quality through antioxidant and antibacterial effects during liquid storage at 17 °C10.1016/j.livsci.2022.104827 ↗
47. Research progress on icariin, a traditional Chinese medicine extract, in the treatment of asthma10.15586/aei.v50i1.490 ↗
48. Effects of icariin on NRG1-ErbB signaling pathways in hippocampus of schizophrenia rats
49. Linker-peptide-mediated one-step purification and immobilization of alpha-L-rhamnosidase from Bacteroides thetaiotaomicron for direct biotransformation from epimedin C to icariin10.1016/j.enzmictec.2022.110131 ↗
50. Icariin promotes osteoblast proliferation and differentiation through a non-nuclear signaling pathway
51. Characterization and osteogenic ability of Mg-F membrane/icariin membrane/beta-tricalcium phosphate scaffolds fabricated by coating process combined with 3D printing
52. Icariin ameliorates memory deficits through regulating brain insulin signaling and glucose transporters in 3?Tg-AD mice10.4103/1673-5374.344840 ↗
53. Chen, M., Wu, J., Luo, Q., Mo, S., Lyu, Y., Wei, Y., and Dong, J. (2016). The Anticancer Properties of Herba Epimedii and Its Main Bioactive Componentsicariin and Icariside II. Nutrients, 8.10.3390/nu8090563 ↗
54. Targeted Delivery of Natural Bioactives and Lipid-nanocargos against Signaling Pathways Involved in Skin Cancer10.2174/0929867327666201104151752 ↗
55. Phyto-Phospholipid Complexation as a Novel Drug Delivery System for Management of Cancer with Better Bioavailability: Current Perspectives and Future Prospects10.2174/1871520620999201110191741 ↗
56. He, Q., Dong, H., Gong, M., Guo, Y., Xia, Q., Gong, J., and Lu, F. (2022). New Therapeutic Horizon of Graves’ Hyperthyroidism: Treatment Regimens Based on Immunology and Ingredients from Traditional Chinese Medicine. Front. Pharmacol., 13.10.3389/fphar.2022.862831 ↗
57. Novel strategies for molecular targeting to cancer10.1111/1440-1681.12556 ↗
58. Therapeutic potential of natural products in glioblastoma treatment: Targeting key glioblas-toma signaling pathways and epigenetic alterations10.1007/s12094-019-02227-3 ↗
59. Alhakamy, N.A., Badr-Eldin, S.M., Alharbi, W.S., Alfaleh, M.A., Al-Hejaili, O.D., Aldawsari, H.M., Eid, B.G., Bakhaidar, R., Drago, F., and Caraci, F. (2021). Development of an Icariin-Loaded Bilosome-Melittin Formulation with Improved Anticancer Activity against Cancerous Pancreatic Cells. Pharmaceuticals, 14.10.3390/ph14121309 ↗
60. Multiple strategies for the treatment of invasive breast carcinoma: A comprehensive prospective10.1016/j.drudis.2021.10.008 ↗
61. Almoshari, Y. (2022). Development, Therapeutic Evaluation and Theranostic Applications of Cubosomes on Cancers: An Up-dated Review. Pharmaceutics, 14.10.3390/pharmaceutics14030600 ↗
62. Effects of icariin on inflammation model stimulated by lipopolysaccharide in vitro and in vivo
63. Inhibitory effects of the aerial parts of Epimedium koreanum on TPA-induced inflammation and tumour promotion in two-stage carcinogenesis in mouse skin10.6000/1927-5951.2016.06.02.1 ↗
64. Icariin attenuates interleukin-1beta-induced inflammatory response in human nucleus pulposus cells10.2174/1381612823666170615112158 ↗
65. Icariin prevents cytokine-induced beta-cell death by inhibiting NF-kappaB signaling
66. Icariin Attenuates M1 Activation of Microglia and Abeta Plaque Accumulation in the Hippocampus and Prefrontal Cortex by Up-Regulating PPARgamma in Restraint/Isolation-Stressed APP/PS1 Mice10.3389/fnins.2019.00291 ↗
67. Ma, A., Ma, A., You, Y., Chen, B., Wang, W., Liu, J., Qi, H., Liang, Y., Li, Y., and Li, C. (2020). Icariin/aspirin composite coating on TiO2 nanotubes surface induce immunomodulatory effect of macro-phage and improve osteoblast activity. Coatings, 10.10.3390/coatings10040427 ↗
68. Long term therapeutic effects of icariin-loaded PLGA microspheres in an experimental model of optic nerve ischemia via modulation of CEBP-beta/G-CSF/noncanonical NF-kappaB axis10.1002/btm2.10289 ↗
69. Effects of Icariin on Improving Erectile Function in Streptozotocin-Induced Diabetic Rats10.1111/j.1743-6109.2011.02421.x ↗
70. Niu, Y., Lin, G., Pan, J., Liu, J., Xu, Y., Cai, Q., Wang, T., Luan, Y., Chen, Y., and Feng, Y. (2021). Deciphering the myth of icariin and synthetic derivatives in improving erectile function from a molecular biology perspective: A narrative review. Transl. Androl. Urol.10.21037/tau-22-232 ↗
71. Effects of Icariin on Reproductive Functions in Male Rats10.3390/molecules19079502 ↗
72. Effect of icariin in combination with daily sildenafil on penile atrophy and erectile dysfunction in a rat model of bilateral cavernous nerves injury10.1111/andr.12341 ↗
73. Mechanism of Action of Icariin in Bone Marrow Mesenchymal Stem Cells
74. Liu, J., Cheng, Q., Wu, X., Zhu, H., Deng, X., Wang, M., Yang, S., Xu, J., Chen, Q., and Li, M. (2022). Icariin Treatment Rescues Diabetes Induced Bone Loss via Scavenging ROS and Activating Primary Cilia/Gli2/Osteocalcin Signaling Pathway. Cells, 11.10.3390/cells11244091 ↗
75. Icariin prevents oestrogen deficiency–induced alveolar bone loss through promoting osteogenesis via STAT310.1111/cpr.12743 ↗
76. Icariin stimulates osteogenic differentiation of rat bone marrow stromal stem cells by increasing TAZ expression10.1016/j.biopha.2017.04.019 ↗
77. Bi, Z., Zhang, W., and Yan, X. (2022). Anti-inflammatory and immunoregulatory effects of icariin and icaritin. Biomed. Pharmacother., 151.10.1016/j.biopha.2022.113180 ↗
78. Icariin regulates stem cell migration for endogenous repair of intervertebral disc degeneration by in-creasing the expression of chemotactic cytokines10.1186/s12906-022-03544-x ↗
79. Icariin promotes osteoblastic differentiation in OVX mice via MAPK signaling pathway revealed by profiling10.1142/S2575900018500027 ↗
80. The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies
81. Icariin attenuates isoproterenol-induced cardiac toxicity in Wistar rats via modulating cGMP level and NF-κB signaling cascade10.1177/0960327119890826 ↗
82. Icariin Acts as a Potential Agent for Preventing Cardiac Ischemia/Reperfusion Injury10.1007/s12013-014-0506-3 ↗
83. Icariin and its metabolites as potential protective phytochemicals against cardiovascular disease: From effects to molecular mechanisms10.1016/j.biopha.2022.112642 ↗
84. Ni, T., Lin, N., Huang, X., Lu, W., Sun, Z., Zhang, J., Lin, H., Chi, J., and Guo, H. (2020). Icariin Ameliorates Diabetic Cardiomyopathy Through Apelin/Sirt3 Signalling to Improve Mitochondrial Dysfunction. Front. Pharmacol., 11.10.3389/fphar.2020.00256 ↗
85. Icariin influences cardiac remodeling following myocardial infarction by regulating the CD147/MMP-9 pathway10.1177/0300060518762060 ↗
86. The Cardioprotective Effect of Icariin on Ischemia–Reperfusion Injury in Isolated Rat Heart: Potential Involvement of the PI 3 K-A kt Signaling Pathway10.1111/1755-5922.12121 ↗
87. Potent Inhibition of Human Phosphodiesterase-5 by Icariin Derivatives10.1021/np800049y ↗
88. Intestinal Absorption Mechanisms of Prenylated Flavonoids Present in the Heat-Processed Epimedium koreanum Nakai (Yin Yanghuo)10.1007/s11095-008-9602-7 ↗
89. Icariin promotes expression of PGC-1α, PPARα, and NRF-1 during cardiomyocyte differentiation of murine embryonic stem cells in vitro 110.1111/j.1745-7254.2007.00648.x ↗
90. Icariine stimulates proliferation and differentiation of human osteoblasts by increasing production of bone morphogenetic protein 210.1097/00029330-200702010-00006 ↗
91. Attenuated 5-HT1A receptor signaling in brains of suicide victims: Involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase10.1046/j.1471-4159.2003.01987.x ↗
92. Drug delivery approaches in addressing clinical pharmacology-related issues: Opportunities and challenges10.1208/s12248-015-9814-9 ↗
93. Icariin and its metabolites regulate lipid metabolism: From effects to molecular mechanisms10.1016/j.biopha.2020.110675 ↗
94. The effect of loading icariin on biocompatibility and bioactivity of porous β-TCP ceramic10.1007/s10856-010-4198-y ↗
95. Choi, S., Noh, S., Lim, C., Kim, H.-J., Jo, H.-S., Min, J., Park, K., and Kim, S. (2020). Icariin-Functionalized Nanodiamonds to Enhance Osteogenic Capacity In Vitro. Nanomaterials, 10.10.3390/nano10102071 ↗
96. Oprita, E.I., Iosageanu, A., and Craciunescu, O. (2022). Progress in Composite Hydrogels and Scaffolds Enriched with Icariin for Osteochondral Defect Healing. Gels, 8.10.3390/gels8100648 ↗
97. Changes in the intestinal absorption mechanism of icariin in the nanocavities of cyclodextrins10.2147/IJN.S33014 ↗
98. Tomorrow’s skeleton staff: Mesenchymal stem cells and the repair of bone and cartilage10.1111/j.1365-2184.2004.00303.x ↗
99. Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold10.1016/j.biomaterials.2005.01.002 ↗
100. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects10.1038/nbt958 ↗